Sac-TMT improved progression-free survival in patients with HR+/HER2– breast cancer.
Andrea Eleazar, MHS
Advertisement
Articles by Andrea Eleazar, MHS
Among patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma that is resectable, Imfinzi with FLOT improved survival.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Trodelvy Plus Keytruda Upholds Quality of Life in TNBC
2
Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer
3
GammaTile May Reduce Risk of Brain Tumor Recurrence or Death
4
Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer
5
